ArticleImmunity2019

Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.

Hiroyuki Nagashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.